Top 10 sur­pris­es for bio­phar­ma in 2020? Cowen's biotech team of­fers a few ideas to chew on

It’s that time of year when peo­ple in the in­dus­try start pay­ing close at­ten­tion to the pos­si­bil­i­ties of what might hap­pen in 2020. Cowen wants to seed that con­ver­sa­tion with its own pre­dic­tions of what lies ahead, with a top 10 list that starts out as most prob­a­ble and ends by en­ter­ing the po­lit­i­cal realm, where seem­ing­ly any­thing can hap­pen.

Let’s get to it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER